NASDAQ:QDEL - Quidel Stock Price, Price Target & More

$55.02 -0.07 (-0.13 %)

(As of 04/25/2018 02:36 PM ET)

Previous Close$55.09

Today's Range$54.16 - $55.09

52-Week Range$23.28 - $57.30

Volume77,158 shs

Average Volume347,694 shs

Market Capitalization$2.07 billion

P/E Ratio-782.29

Dividend YieldN/A

Beta0.89

About Quidel (NASDAQ:QDEL)

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. It also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, the company offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

Receive QDEL News and Ratings via Email

Sign-up to receive the latest news and ratings for QDEL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances

Sub-IndustryHealth Care Supplies

SectorMedical

SymbolNASDAQ:QDEL

CUSIP74838J10

Webwww.quidel.com

Phone858-552-1100

Debt

Debt-to-Equity Ratio1.66%

Current Ratio2.58%

Quick Ratio2.06%

Price-To-Earnings

Trailing P/E Ratio-782.29

Forward P/E Ratio23.12

P/E Growth0.93

Sales & Book Value

Annual Sales$277.74 million

Price / Sales7.39

Cash Flow$1.0809 per share

Price / Cash50.90

Book Value$6.68 per share

Price / Book8.24

Profitability

EPS (Most Recent Fiscal Year)($0.07)

Net Income$-8,160,000.00

Net Margins-2.94%

Return on Equity-3.02%

Return on Assets-1.23%

Miscellaneous

Employees1,193

Outstanding Shares37,280,000

How to Become a New Pot Stock Millionaire

Quidel (NASDAQ:QDEL) Frequently Asked Questions

What is Quidel's stock symbol?

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

How were Quidel's earnings last quarter?

Quidel Co. (NASDAQ:QDEL) released its earnings results on Wednesday, February, 21st. The company reported $0.56 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.14) by $0.70. The firm earned $114.90 million during the quarter, compared to analysts' expectations of $115.06 million. Quidel had a negative return on equity of 3.02% and a negative net margin of 2.94%. The company's revenue was up 117.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.17 EPS. View Quidel's Earnings History.

When is Quidel's next earnings date?

Quidel is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Quidel.

What price target have analysts set for QDEL?

8 analysts have issued 1-year price targets for Quidel's stock. Their forecasts range from $47.00 to $64.00. On average, they expect Quidel's stock price to reach $58.50 in the next twelve months. View Analyst Ratings for Quidel.

Are investors shorting Quidel?

Quidel saw a drop in short interest during the month of March. As of March 29th, there was short interest totalling 3,255,890 shares, a drop of 25.6% from the March 15th total of 4,376,368 shares. Based on an average daily volume of 422,117 shares, the days-to-cover ratio is presently 7.7 days. Approximately 10.9% of the company's stock are short sold.

Who are some of Quidel's key competitors?

Some companies that are related to Quidel include Neogen (NEOG), Immunomedics (IMMU), Myriad Genetics (MYGN), Intellia Therapeutics (NTLA), New England Nuclear (LNTH), Meridian Bioscience (VIVO), Oxford Immunotec Global (OXFD), Nymox Pharmaceutical (NYMX), Quotient (QTNT), Trinity Biotech (TRIB), Vermillion (VRML), Celldex Therapeutics (CLDX), AspenBio Pharma (RIOT), Akers Biosciences (AKER) and ImmuCell (ICCC).

Who are Quidel's key executives?

Quidel's management team includes the folowing people:

Mr. Douglas C. Bryant, Pres, CEO & Director (Age 60)
Mr. Randall J. Steward, CFO & Principal Accounting Officer (Age 64)
Mr. Robert J. Bujarski, Sr. VP of Bus. Devel., Gen. Counsel & Corp. Sec. (Age 50)
Dr. Werner Kroll, Sr. VP of R&D (Age 61)
Mr. Edward Keith Russell, Sr. VP of North America Operations (Age 50)

Has Quidel been receiving favorable news coverage?

Media coverage about QDEL stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Quidel earned a coverage optimism score of 0.25 on Accern's scale. They also gave news headlines about the company an impact score of 44.74 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Quidel?

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quidel's stock price today?

One share of QDEL stock can currently be purchased for approximately $55.02.

How big of a company is Quidel?

Quidel has a market capitalization of $2.07 billion and generates $277.74 million in revenue each year. The company earns $-8,160,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. Quidel employs 1,193 workers across the globe.

How can I contact Quidel?

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]

MarketBeat Community Rating for Quidel (QDEL)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		232 (Vote Outperform)
Underperform Votes:		213 (Vote Underperform)
Total Votes:		445

MarketBeat's community ratings are surveys of what our community members think about Quidel and other stocks. Vote "Outperform" if you believe QDEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QDEL will underperform the S&P 500 over the long term. You may vote once every thirty days.

Quidel (NASDAQ:QDEL) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

8 Wall Street analysts have issued ratings and price targets for Quidel in the last 12 months. Their average twelve-month price target is $58.50, suggesting that the stock has a possible upside of 6.32%. The high price target for QDEL is $64.00 and the low price target for QDEL is $47.00. There are currently 6 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	3.25	3.25	3.00	2.83
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 6 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 6 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$58.50	$55.50	$54.20	$47.50
Price Target Upside:	6.32% upside	8.53% upside	13.84% upside	12.19% upside

Quidel (NASDAQ:QDEL) Consensus Price Target History

Price Target History for Quidel (NASDAQ:QDEL)

Quidel (NASDAQ:QDEL) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/13/2018	William Blair	Reiterated Rating	Buy		Low
4/5/2018	Canaccord Genuity	Boost Price Target	Buy	$55.00 -> $64.00	Low
4/4/2018	Piper Jaffray	Reiterated Rating	Buy	$63.00	Low
4/2/2018	Barclays	Boost Price Target	Overweight -> Overweight	$60.00 -> $63.00	Low
3/26/2018	Craig Hallum	Initiated Coverage	Buy	$62.00	Low
3/8/2018	Raymond James	Upgrade	Outperform -> Strong-Buy	$55.00 -> $47.00	Medium
3/8/2018	UBS	Upgrade	Outperform -> Strong-Buy		High
1/4/2018	CL King	Upgrade	Neutral -> Buy	$52.00	High

(Data available from 4/25/2016 forward)

Quidel (NASDAQ:QDEL) Earnings History and Estimates Chart

Earnings by Quarter for Quidel (NASDAQ:QDEL)

Quidel (NASDAQ:QDEL) Earnings Estimates

2018 EPS Consensus Estimate: $2.27

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.89	$0.89	$0.89
Q2 2018	1	$0.14	$0.14	$0.14
Q3 2018	1	$0.52	$0.52	$0.52
Q4 2018	1	$0.72	$0.72	$0.72

Quidel (NASDAQ QDEL) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/8/2018		$0.94					N/A
2/21/2018	Q4 2017	($0.14)	$0.56	$115.06 million	$114.90 million	View	Listen
11/1/2017	Q3 2017	$0.05	($0.16)	$50.47 million	$50.89 million	View	N/A
7/26/2017	Q2 2017	($0.17)	($0.35)	$41.91 million	$38.30 million	View	N/A
4/24/2017	Q1 2017	$0.15	$0.45	$61.85 million	$73.70 million	View	N/A
2/8/2017	Q416	$0.02	$0.17	$58.42 million	$52.80 million	View	Listen
10/26/2016	Q316	($0.02)	$0.10	$50.88 million	$49.30 million	View	Listen
7/27/2016	Q216	($0.25)	($0.11)	$37.98 million	$39.10 million	View	Listen
4/27/2016	Q116	($0.07)	$0.02	$49.21 million	$50.30 million	View	Listen
2/17/2016	Q415	$0.05	$0.10	$54.01 million	$52.40 million	View	Listen
10/28/2015	Q315	($0.14)	$0.05	$43.48 million	$46.80 million	View	Listen
7/22/2015	Q215	($0.25)	($0.14)	$34.17 million	$34.87 million	View	Listen
4/23/2015	Q115	$0.12	$0.30	$61.22 million	$61.30 million	View	Listen
2/11/2015	Q414	$0.10	$0.37	$60.61 million	$63.60 million	View	Listen
10/21/2014	Q314	($0.12)	($0.01)	$37.80 million	$40.90 million	View	Listen
7/22/2014	Q214	($0.16)	($0.10)	$31.90 million	$31.50 million	View	Listen
4/23/2014	Q114	$0.30	$0.08	$63.26 million	$46.70 million	View	Listen
2/11/2014	Q413	$0.09	$0.20	$48.67 million	$50.00 million	View	Listen
10/23/2013	Q313	($0.07)	($0.02)	$37.32 million	$33.50 million	View	Listen
7/30/2013	Q2 2013	($0.11)	($0.06)	$33.24 million	$29.71 million	View	Listen
4/23/2013	Q1 2013	$0.46	$0.49	$62.63 million	$61.99 million	View	N/A
2/12/2013	Q4 2012	$0.29	$0.26	$53.30 million	$53.93 million	View	Listen
10/23/2012		($0.03)	$0.08			View	N/A
7/25/2012		($0.08)	$0.01			View	N/A
4/25/2012	Q1 2012	$0.06	$0.04			View	N/A
2/29/2012		$0.06	$0.15			View	N/A
10/25/2011		($0.06)	($0.03)			View	N/A
8/2/2011		($0.07)	($0.04)			View	N/A
4/28/2011		$0.33	$0.35			View	N/A
2/24/2011		($0.01)	$0.02			View	N/A
10/27/2010	Q3 2010	($0.04)	($0.06)			View	N/A
7/29/2010	Q2 2010	($0.06)	($0.03)			View	N/A
4/29/2010	Q1 2010	($0.02)	($0.04)			View	N/A
2/11/2010	Q4 2009	$0.47	$0.68			View	N/A
10/16/2009	Q3 2009	$0.27	$0.50			View	N/A
7/22/2009	Q2 2009	($0.01)	$0.04			View	N/A
4/22/2009	Q1 2009	($0.02)	($0.06)			View	N/A
2/25/2009	Q4 2008	$0.21	$0.19			View	N/A
10/22/2008	Q3 2008	$0.11	$0.15			View	N/A
7/23/2008	Q2 2008	($0.04)	($0.02)			View	N/A
4/23/2008	Q1 2008	$0.23	$0.26			View	N/A
2/21/2008	Q4 2007	$0.27	$0.25			View	N/A

(Earnings results data provided by Zacks Investment Research)

Quidel (NASDAQ:QDEL) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Quidel (NASDAQ QDEL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 87.27%

Insider Trading History for Quidel (NASDAQ:QDEL)

Institutional Ownership by Quarter for Quidel (NASDAQ:QDEL)

Quidel (NASDAQ QDEL) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/29/2018	Douglas C Bryant	CEO	Sell	36,000	$51.63	$1,858,680.00	306,313
3/27/2018	Douglas C Bryant	CEO	Sell	12,000	$51.51	$618,120.00	306,313
2/28/2018	Douglas C Bryant	CEO	Sell	36,000	$44.32	$1,595,520.00	302,843
2/26/2018	Douglas C Bryant	CEO	Sell	12,000	$44.63	$535,560.00	302,843
1/30/2018	Douglas C Bryant	CEO	Sell	12,000	$46.82	$561,840.00	286,493
1/22/2018	Jack W Schuler	Director	Sell	12,000	$48.50	$582,000.00
1/5/2018	Jack W Schuler	Director	Sell	4,000	$47.02	$188,080.00
1/4/2018	Ratan S Borkar	SVP	Sell	29,880	$45.15	$1,349,082.00	20,253
12/29/2017	Douglas C Bryant	CEO	Sell	36,000	$44.10	$1,587,600.00	286,493
12/28/2017	Douglas C Bryant	CEO	Sell	12,000	$44.12	$529,440.00	286,493
12/27/2017	Douglas C Bryant	CEO	Sell	12,000	$44.50	$534,000.00	286,493
12/21/2017	Jack W Schuler	Director	Sell	4,000	$44.60	$178,400.00	3,365,553
12/15/2017	Robert Joseph Bujarski	SVP	Sell	110,704	$39.78	$4,403,805.12	79,797
12/12/2017	Randall J Steward	CFO	Sell	36,383	$40.09	$1,458,594.47	56,290
12/8/2017	Werner Kroll	SVP	Sell	16,358	$40.44	$661,517.52	10,818
12/5/2017	Thomas D Brown	Director	Sell	12,154	$39.62	$481,541.48	57,179
12/4/2017	Ratan S Borkar	SVP	Sell	24,781	$40.05	$992,479.05	10,811
11/30/2017	Douglas C Bryant	CEO	Sell	36,000	$37.36	$1,344,960.00	296,493
11/28/2017	Douglas C Bryant	CEO	Sell	12,000	$36.72	$440,640.00	296,493
11/9/2017	Ratan S Borkar	SVP	Sell	7,965	$38.91	$309,918.15	11,084
11/6/2017	Werner Kroll	SVP	Sell	7,565	$39.50	$298,817.50	10,261
10/30/2017	Douglas C Bryant	CEO	Sell	12,000	$41.15	$493,800.00	296,493
10/27/2017	Douglas C Bryant	CEO	Sell	12,000	$42.29	$507,480.00	296,493
9/29/2017	Douglas C Bryant	CEO	Sell	36,000	$42.91	$1,544,760.00	296,493
9/28/2017	Douglas C Bryant	CEO	Sell	12,000	$42.86	$514,320.00	296,493
9/27/2017	Douglas C Bryant	CEO	Sell	12,000	$42.17	$506,040.00	296,493
8/31/2017	Douglas C Bryant	CEO	Sell	36,000	$34.44	$1,239,840.00	296,493
7/31/2017	Douglas C Bryant	CEO	Sell	36,000	$33.83	$1,217,880.00	296,493
7/28/2017	Michael Donald Jr. Abney	SVP	Sell	1,173	$33.83	$39,682.59
7/28/2017	Randall J Steward	CFO	Sell	94,215	$34.09	$3,211,789.35	79,907
6/30/2017	Douglas C Bryant	CEO	Sell	36,000	$27.30	$982,800.00	296,493
5/31/2017	Douglas C Bryant	CEO	Sell	36,000	$24.98	$899,280.00	296,493
5/30/2017	Douglas C Bryant	CEO	Sell	12,000	$25.10	$301,200.00	296,493
5/26/2017	Douglas C Bryant	CEO	Sell	12,000	$24.90	$298,800.00	296,493
5/2/2017	Robert Joseph Bujarski	SVP	Sell	43,225	$24.27	$1,049,070.75	50,984
5/1/2017	Robert Joseph Bujarski	SVP	Sell	33,225	$24.20	$804,045.00	50,984
4/28/2017	Douglas C Bryant	CEO	Sell	36,000	$24.16	$869,760.00	296,493
3/31/2017	Douglas C Bryant	CEO	Sell	37,080	$22.50	$834,300.00	297,573
2/28/2017	Douglas C. Bryant	CEO	Sell	106,920	$21.39	$2,287,018.80
12/1/2016	Robert Joseph Bujarski	SVP	Sell	60,000	$22.84	$1,370,400.00	74,896
11/30/2016	Douglas C Bryant	CEO	Sell	72,000	$22.89	$1,648,080.00	298,011
11/29/2016	Douglas C Bryant	CEO	Sell	24,000	$22.84	$548,160.00	298,011
11/28/2016	Douglas C Bryant	CEO	Sell	24,000	$23.02	$552,480.00	298,011
11/25/2016	John Tamerius	SVP	Sell	8,878	$23.50	$208,633.00	32,418
9/30/2016	Douglas C Bryant	CEO	Sell	69,168	$21.76	$1,505,095.68	291,121
8/30/2016	Douglas C Bryant	CEO	Sell	2,832	$22.00	$62,304.00	276,843
8/9/2016	Robert Joseph Bujarski	SVP	Sell	22,057	$22.58	$498,047.06	60,100
8/1/2016	John Tamerius	SVP	Sell	7,000	$23.02	$161,140.00	18,540
2/19/2016	Douglas C. Bryant	CEO	Buy	3,700	$13.91	$51,467.00
12/2/2015	John Tamerius	SVP	Sell	21,109	$21.95	$463,342.55	26,854
10/30/2015	Douglas C Bryant	CEO	Buy	20,000	$19.76	$395,200.00	249,404
10/3/2014	John Tamerius	SVP	Sell	5,000	$28.00	$140,000.00
9/18/2014	John Tamerius	SVP	Sell	10,000	$26.50	$265,000.00
7/24/2014	Douglas C Bryant	CEO	Buy	20,000	$24.12	$482,400.00
7/23/2014	John Tamerius	SVP	Sell	15,000	$24.50	$367,500.00
6/24/2014	John Tamerius	SVP	Sell	5,000	$23.06	$115,300.00
2/26/2014	John Tamerius	SVP	Sell	47,246	$27.69	$1,308,241.74	32,019
2/13/2014	Rodney Dammeyer	Director	Sell	26,000	$27.70	$720,200.00
10/29/2013	Mark Pulido	Director	Sell	12,750	$25.31	$322,702.50
5/29/2013	Robert Joseph Bujarski	SVP	Sell	28,808	$23.16	$667,193.28
5/17/2013	Robert Joseph Bujarski	SVP	Sell	27,479	$23.12	$635,314.48

(Data available from 1/1/2013 forward)

Quidel (NASDAQ QDEL) News Headlines

Source:

Date	Headline
	Quidel (QDEL) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - April 25 at 9:58 AM
	Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018 finance.yahoo.com - April 23 at 4:42 PM
	Reviewing Nymox Pharmaceutical (NYMX) & Quidel (QDEL) www.americanbankingnews.com - April 20 at 7:34 PM
	Stock Traders Buy High Volume of Put Options on Quidel (QDEL) www.americanbankingnews.com - April 19 at 8:32 AM
	Quidel (QDEL) Upgraded to Outperform by William Blair www.americanbankingnews.com - April 17 at 6:29 PM
	Quidel (QDEL) Set to Announce Quarterly Earnings on Monday www.americanbankingnews.com - April 16 at 3:32 AM
	Quidel (QDEL) Price Target Increased to $39.00 by Analysts at Barclays www.americanbankingnews.com - April 15 at 12:01 PM
	Quidel (QDEL) Price Target Raised to $41.00 www.americanbankingnews.com - April 15 at 12:00 PM
	Quidel Co. (QDEL) Short Interest Down 25.6% in March www.americanbankingnews.com - April 15 at 2:01 AM
	Quidel (QDEL) Downgraded to "Hold" at BidaskClub www.americanbankingnews.com - April 14 at 9:51 PM
	Quidel's (QDEL) "Buy" Rating Reaffirmed at William Blair www.americanbankingnews.com - April 14 at 7:21 AM
	$145.47 Million in Sales Expected for Quidel Co. (QDEL) This Quarter www.americanbankingnews.com - April 11 at 2:38 AM
	Quidel Co. (QDEL) Expected to Post Earnings of $0.95 Per Share www.americanbankingnews.com - April 9 at 3:14 PM
	Quidel Co. (QDEL) Given Consensus Recommendation of "Buy" by Analysts www.americanbankingnews.com - April 8 at 3:22 AM
	Is the Options Market Predicting a Spike in Quidel (QDEL) Stock? finance.yahoo.com - April 6 at 9:25 AM
	Q1 2018 Earnings Estimate for Quidel Co. (QDEL) Issued By William Blair www.americanbankingnews.com - April 6 at 6:23 AM
	Quidel's (QDEL) Buy Rating Reiterated at Canaccord Genuity www.americanbankingnews.com - April 5 at 4:38 PM
	Quidel (QDEL) Earns Buy Rating from Canaccord Genuity www.americanbankingnews.com - April 5 at 12:28 PM
	BRIEF-Quidel Corp Says Increased Size Of Board To Eight Members - SEC Filing www.reuters.com - April 5 at 11:11 AM
	Quidel (QDEL) Stock Rating Reaffirmed by Piper Jaffray www.americanbankingnews.com - April 4 at 6:26 AM
	Quidel (QDEL) Upgraded by ValuEngine to Hold www.americanbankingnews.com - April 3 at 8:57 AM
	Quidel's (QDEL) Buy Rating Reaffirmed at Barclays www.americanbankingnews.com - April 2 at 1:30 PM
	Douglas C. Bryant Sells 12,000 Shares of Quidel Co. (QDEL) Stock www.americanbankingnews.com - March 29 at 10:28 PM
	Quidel Co. (QDEL) CEO Douglas C. Bryant Sells 36,000 Shares www.americanbankingnews.com - March 29 at 10:10 PM
	Quidel (QDEL) Downgraded to Sell at ValuEngine www.americanbankingnews.com - March 28 at 11:56 AM
	Quidel (QDEL) Upgraded to "Hold" by Zacks Investment Research www.americanbankingnews.com - March 28 at 11:04 AM
	Quidel to Host 2018 Analyst and Investor Day in Chicago finance.yahoo.com - March 28 at 9:20 AM
	Quidel (QDEL) Upgraded to "Strong-Buy" at BidaskClub www.americanbankingnews.com - March 27 at 4:34 PM
	Quidel (QDEL) Price Target Increased to $60.00 by Analysts at Barclays www.americanbankingnews.com - March 27 at 10:59 AM
	Quidel (QDEL) Earns Buy Rating from Analysts at Craig Hallum www.americanbankingnews.com - March 26 at 5:28 PM
	Brokerages Anticipate Quidel Co. (QDEL) Will Announce Quarterly Sales of $140.09 Million www.americanbankingnews.com - March 25 at 4:14 AM
	Quidel Co. (QDEL) Given Average Recommendation of "Buy" by Brokerages www.americanbankingnews.com - March 14 at 3:26 AM
	Comparing Quidel (QDEL) & Restoration Robotics (HAIR) www.americanbankingnews.com - March 12 at 7:09 PM
	Quidel (QDEL) Upgraded by BidaskClub to "Buy" www.americanbankingnews.com - March 10 at 2:33 PM
	Quidel (QDEL) Upgraded at UBS Group www.americanbankingnews.com - March 8 at 11:40 PM
	Quidel (QDEL) Upgraded by Raymond James Financial to Strong-Buy www.americanbankingnews.com - March 8 at 5:52 PM
	Near-Term Catalysts, Long-Term Opportunities Make Quidel A Strong Buy, Says Raymond James finance.yahoo.com - March 8 at 5:46 PM
	Quidel Co. (QDEL) Expected to Announce Quarterly Sales of $140.09 Million www.americanbankingnews.com - March 8 at 7:40 AM
	Quidel Co. (QDEL) Expected to Post Earnings of $0.43 Per Share www.americanbankingnews.com - March 6 at 11:26 AM
	Quidel Co. (QDEL) Shares Bought by Tamarack Advisers LP www.americanbankingnews.com - March 6 at 10:30 AM
	Gagnon Securities LLC Purchases New Stake in Quidel Co. (QDEL) www.americanbankingnews.com - March 3 at 3:01 PM
	EAM Investors LLC Has $1.98 Million Position in Quidel Co. (QDEL) www.americanbankingnews.com - March 2 at 12:57 PM
	OppenheimerFunds Inc. Has $27.31 Million Stake in Quidel Co. (QDEL) www.americanbankingnews.com - March 2 at 11:52 AM
	Quidel Co. (QDEL) CEO Douglas C. Bryant Sells 12,000 Shares www.americanbankingnews.com - March 1 at 12:38 AM
	Quidel Co. (QDEL) CEO Sells $1,595,520.00 in Stock www.americanbankingnews.com - March 1 at 12:20 AM
	Quidel to Present at Upcoming Conferences finance.yahoo.com - February 27 at 9:07 AM
	Baird Financial Group Inc. Buys 5,000 Shares of Quidel Co. (QDEL) www.americanbankingnews.com - February 26 at 4:42 AM
	Zacks Investment Research Upgrades Quidel (QDEL) to Hold www.americanbankingnews.com - February 23 at 10:06 AM
	Quidel (QDEL) Posts Earnings Results, Beats Estimates By $0.36 EPS www.americanbankingnews.com - February 21 at 9:46 PM
	Quidel Reports Fourth Quarter and Full Year 2017 Financial Results finance.yahoo.com - February 21 at 4:55 PM

Quidel (NASDAQ:QDEL) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Quidel (NASDAQ:QDEL) Income Statement, Balance Sheet and Cash Flow Statement

Quidel (NASDAQ QDEL) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff